ARCHIVES

Taking Profit Out Of ESAs, Insurer Sending Controversial Drugs Directly To Patients.

This article is from The Cancer Letter archive.

Vol. 36 No. 13 | April 9, 2010

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

SWOG Wins Funding For H. Pylori Trial.

November 21, 2008

In Brief: FDA Commissioner Kessler Named Dean, Yale Medical School, Effective July 1

February 21, 1997

Grassley Seeks Data On Sponsored Travel By NCI Scientists

October 29, 2010

FDA’s New Guideline Proposal Meets More NCI Objections

March 19, 1976

NCI “Leadership Vacuum” Deepened?

December 22, 1994